Skip to main content
Funded Studies

Ruth Luthi-Carter, PhD

Professor of Neurobiology of Behaviour at University of Leicester

Research Fellow at AC Immune SA

Location: Leicester United Kingdom

Ruth Luthi-Carter, PhD, started her independent research group in 2003 at the Swiss Federal Institute of Technology (EPFL) in Switzerland and in 2012 became a full professor at the University of Leicester. Her research group has undertaken groundbreaking work to discover new potential therapeutic targets for brain diseases. She recently joined AC Immune SA as Research Fellow, bringing her molecular neurobiology expertise to the company's translational research.

Dr. Luthi-Carter earned her doctorate in pharmacology and molecular sciences from Johns Hopkins University, where she worked with Professor Joseph Coyle to uncover FOLH1 as the gene encoding an enzyme that subsequently became a therapeutic target for brain diseases and injury. She subsequently undertook postdoctoral research with Professor Anne Young at Harvard’s MassGeneral Institute for Neurodegenerative Disease.

Associated Grants

  • Development of Novel Brain-penetrant Inflammasome Inhibitors as Potential Therapeutics for Parkinson’s Disease


  • Development of a Small-molecule Inhibitor Targeting Intracellular Alpha-synuclein Pathology


  • Optimization of Morphomer-Based Alpha-synuclein PET Tracers


  • Enhancing Mitochondria Quality Control in Parkinson’s via Activation of the Caseinolytic Peptidase


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.